| Target Price | CHF170.34 |
| Price | CHF161.50 |
| Potential | 5.47% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Richemont 2026 . The average Richemont target price is CHF170.34. This is 5.47% higher than the current stock price. The highest price target is CHF199.50 23.53% , the lowest is CHF133.32 17.45% . | |
| A rating was issued by 30 analysts: 20 Analysts recommend Richemont to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2026 of 5.47% . Most analysts recommend the Richemont stock at Purchase. |
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 19.79 | 20.42 |
| 3.80% | 3.20% | |
| EBITDA Margin | 21.23% | 26.96% |
| 10.50% | 26.99% | |
| Net Margin | 12.86% | 16.20% |
| 12.21% | 26.01% |
24 Analysts have issued a sales forecast Richemont 2026 . The average Richemont sales estimate is CHF20.4b . This is 3.20% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF22.1b 11.73% , the lowest is CHF19.3b 2.33% .
This results in the following potential growth metrics:
| 2025 | CHF19.8b | 3.80% |
|---|---|---|
| 2026 | CHF20.4b | 3.20% |
| 2027 | CHF21.8b | 6.64% |
| 2028 | CHF23.3b | 7.08% |
| 2029 | CHF25.1b | 7.60% |
| 2030 | CHF26.9b | 7.39% |
| 2031 | CHF28.8b | 6.88% |
| 2032 | CHF30.7b | 6.65% |
25 Richemont Analysts have issued a net profit forecast 2026. The average Richemont net profit estimate is CHF3.3b . This is 30.06% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF3.9b 51.92% , the lowest is CHF2.9b 14.19% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | CHF2.5b | 16.47% |
|---|---|---|
| 2026 | CHF3.3b | 30.06% |
| 2027 | CHF3.8b | 14.22% |
| 2028 | CHF4.4b | 15.21% |
| 2029 | CHF4.8b | 9.53% |
| 2030 | CHF5.2b | 8.90% |
| 2031 | CHF5.4b | 3.50% |
| 2032 | CHF5.7b | 5.80% |
| 2025 | 12.86% | 12.21% |
|---|---|---|
| 2026 | 16.20% | 26.01% |
| 2027 | 17.35% | 7.10% |
| 2028 | 18.67% | 7.61% |
| 2029 | 19.01% | 1.82% |
| 2030 | 19.27% | 1.37% |
| 2031 | 18.67% | 3.11% |
| 2032 | 18.52% | 0.80% |
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 4.32 | 5.63 |
| 14.89% | 30.32% | |
| P/E | 29.16 | |
| EV/Sales | 4.46 |
25 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF5.63 . This is 30.63% higher than earnings per share in the financial year 2025. The highest EPS forecast is CHF6.57 52.44% , the lowest is CHF4.94 14.62% .
This results in the following potential growth metrics and future valuations:
| 2025 | CHF4.32 | 14.89% |
|---|---|---|
| 2026 | CHF5.63 | 30.32% |
| 2027 | CHF6.43 | 14.21% |
| 2028 | CHF7.40 | 15.09% |
| 2029 | CHF8.11 | 9.59% |
| 2030 | CHF8.83 | 8.88% |
| 2031 | CHF9.14 | 3.51% |
| 2032 | CHF9.67 | 5.80% |
| Current | 38.07 | 33.94% |
|---|---|---|
| 2026 | 29.16 | 23.41% |
| 2027 | 25.53 | 12.45% |
| 2028 | 22.16 | 13.20% |
| 2029 | 20.23 | 8.71% |
| 2030 | 18.58 | 8.16% |
| 2031 | 17.95 | 3.39% |
| 2032 | 16.97 | 5.46% |
Based on analysts' sales estimates for 2026, the Richemont stock is valued at an EV/Sales of 4.46 and an P/S ratio of 4.62 .
This results in the following potential growth metrics and future valuations:
| Current | 4.60 | 41.54% |
|---|---|---|
| 2026 | 4.46 | 3.10% |
| 2027 | 4.18 | 6.23% |
| 2028 | 3.90 | 6.62% |
| 2029 | 3.63 | 7.06% |
| 2030 | 3.38 | 6.88% |
| 2031 | 3.16 | 6.44% |
| 2032 | 2.96 | 6.23% |
| Current | 4.77 | 42.80% |
|---|---|---|
| 2026 | 4.62 | 3.10% |
| 2027 | 4.33 | 6.23% |
| 2028 | 4.05 | 6.61% |
| 2029 | 3.76 | 7.06% |
| 2030 | 3.50 | 6.88% |
| 2031 | 3.28 | 6.44% |
| 2032 | 3.07 | 6.23% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Buy
➜
Buy
|
Unchanged | Sep 10 2025 |
| DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Sep 08 2025 |
| HSBC GLOBAL INVESTMENT RESEARCH |
Buy
➜
Hold
|
Downgrade | Aug 25 2025 |
| TD COWEN |
Buy
➜
Buy
|
Unchanged | Aug 19 2025 |
| BERENBERG |
Hold
➜
Hold
|
Unchanged | Jul 30 2025 |
| CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED |
Neutral
➜
Neutral
|
Unchanged | Jul 21 2025 |
| TD COWEN |
Buy
➜
Buy
|
Unchanged | Jul 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Sep 10 2025 |
|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Sep 08 2025 |
|
Downgrade
HSBC GLOBAL INVESTMENT RESEARCH:
Buy
➜
Hold
|
Aug 25 2025 |
|
Unchanged
TD COWEN:
Buy
➜
Buy
|
Aug 19 2025 |
|
Unchanged
BERENBERG:
Hold
➜
Hold
|
Jul 30 2025 |
|
Unchanged
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED:
Neutral
➜
Neutral
|
Jul 21 2025 |
|
Unchanged
TD COWEN:
Buy
➜
Buy
|
Jul 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


